Press Releases -> Pharmaceuticals & Biotech Syndicate content

Apr 13, 2018
  • Autologous adipose tissue-derived mesenchymal stem cells applied to Alzheimer’s patients for the first time
  • World’s first intravenous injection of stem cells over 10 applications developed by Biostar Stem Cell Research Institute and Dr. Jeong-Chan Ra
  • Treatment can be applied to mild-to-...
  • Mar 21, 2018

    United Arab Emirates, Dubai, 21 March 2018 --( ASIA TODAY )-- INDEX Conferences & Exhibitions, member of INDEX Holding, is proud to announce the launch of Asia Derma, the Asia-Pacific Dermatology and Aesthetic Conference & Exhibition. The event will be held from the 5th to the 7th December 2018 at SUNTEC...

    Mar 20, 2018

    WUXI, China and BETHLEHEM, Pa., March 21, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has selected 4,000 liter (L) Custom Single Run (...

    Mar 16, 2018

    Singapore, March 15, 2018 - The Institute of Bioengineering and Nanotechnology (IBN) of A*STAR has reported superior results using new green tea-based nanocarriers to kill liver cancer cells, compared to existing drug delivery systems. IBN Team Leader and Principal Research Scientist, Dr Motoichi Kurisawa, and his...

    Mar 16, 2018

    Dubai --( ASIA TODAY )-- United Arab Emirates, 16 March 2018: Under the patronage of His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of the Dubai Health Authority, the 18th edition of Dubai World Dermatology and Laser Conference and Exhibition – Dubai Derma...

    Mar 13, 2018

    Singapore --( ASIA TODAY )-- A research collaboration between A*STAR’s Genome Institute of Singapore (GIS) and Institute of Molecular and Cellular Biology (IMCB), and the Stanford University School of Medicine, has discovered methods to efficiently generate pure liver cells from human stem cells. This could lead to...

    Mar 04, 2018

    SINGAPORE, March 5, 2018 /PRNewswire/ -- Moleac, a biopharmaceutical company focused on research and development of new medicines for central nervous system (CNS) diseases and injuries, today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational new drug (IND) application for a...

    Feb 26, 2018

    In the United States, Lusutrombopag Granted Priority Review by the FDA

    Feb 22, 2018

    Dubai – United Arab Emirates, 22 February 2018: Under the patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of Dubai Health Authority, the 23rd edition of Dubai International Pharmaceutical and Technology Conference and Exhibition – DUPHAT 2018...

    Feb 20, 2018

    BALTIMORE & MEMPHIS, Tenn.--(BUSINESS WIRE)--Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has completed a management buyout (“MBO”) and raised capital from a group of global investment firms including...

    Feb 12, 2018

    An international multi-disciplinary research team led by scientists at the Hong Kong University of Science and Technology (HKUST) has discovered for the first time a computational framework that could map out the fitness landscape of a crucial protein in the human immunodeficiency virus (HIV), potentially paving...

    Feb 12, 2018

    HILDEN, Germany & TOKYO--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection. QFT-Plus is the fourth...

    Feb 03, 2018

    Novel approach of light delivery suppresses tumour growth in regions deep in the body

    A team of scientists from the National University of Singapore (NUS) has developed a way to wirelessly deliver light into deep regions of the body to activate light-sensitive drugs for photodynamic therapy (PDT).

    Jan 30, 2018

    (Hong Kong, 31 January 2018) ---- The largest Chinese medicine injections, soft capsules and granules manufacturer in PRC, China Shineway Pharmaceutical Group Limited, and collectively with its subsidiaries ("China Shineway") (SEHK stock code: 2877) today told investors in a monthly newsflash the following:

    Jan 08, 2018

    BOTHELL, Washington and BERKLEY, California and COPENHAGEN, Denmark and HEIDELBERG, Germany and CHIBA, Japan and YOKOHAMA, Japan, Jan. 9, 2018 /PRNewswire/ -- AGC Biologics, a convergence of Asahi Glass Company (AGC) Bioscience, Biomeva GmbH, and CMC Biologics, announced today that effective January 8, 2018, the...

    Jan 08, 2018

    SYDNEY, Jan. 8, 2018 /PRNewswire/ -- Leading Asia Pacific CRO Novotech has won Asia Pacific Biotech CRO Company of The Year award in Frost & Sullivan's 2017 Best Practice Awards.

    Dec 16, 2017

    On December 15th, the Tsinghua Laboratory of Brain and Intelligence (THBI) and the Future Laboratory, Tsinghua University (THFL), were officially unveiled.

    Dec 04, 2017

    Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-025, a Selective MMP-12 Inhibitor.

    Oct 19, 2017

    Perth, Kuala Lumpur and Ontario - (ACN Newswire) - Australian Securities Exchange-listed food ingredient specialist Holista CollTech Ltd (ASX: HCT, "Holista") announced today that it has developed a breakthrough noodle formula certified to have a low Glycemic Index ("GI") - opening a major market for a healthier...

    Oct 07, 2017

    Artemisinin-ALA co-treatment could kill cancer cells and suppress tumour growth with fewer side effects

    Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore (NUS) recently showed that its anti-cancer...

    Aug 13, 2017

    The Ministry of Science, ICT, and Future Planning reported that Professor MIN Dal-Hee from the Department of Chemistry at SNU led a team of researchers to develop nanomaterial that aids the photosensitization process used in cancer treatment.

    Certain types of cancer treatments employ photodynamic therapy,...

    Jul 28, 2017

    A research team led by Prof SUN Fei, Assistant Professor of Chemical & Biological Engineering at The Hong Kong University of Science and Technology (HKUST), has created a new protein-based stimuli-responsive smart hydrogel that could open doors for future material biology and biomedical applications.